Edition:
India

OvaScience Inc (OVAS.OQ)

OVAS.OQ on NASDAQ Stock Exchange Global Market

1.37USD
17 Nov 2017
Change (% chg)

$-0.01 (-0.72%)
Prev Close
$1.38
Open
$1.38
Day's High
$1.41
Day's Low
$1.37
Volume
24,678
Avg. Vol
27,748
52-wk High
$4.19
52-wk Low
$1.26

Chart for

About

OvaScience, Inc. is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Company's portfolio of fertility treatment options uses its technology, including methods to identify and isolate Egg precursor (EggPC) cells from a patient's... (more)

Overall

Beta: 3.53
Market Cap(Mil.): $49.96
Shares Outstanding(Mil.): 35.69
Dividend: --
Yield (%): --

Financials

BRIEF-Ovascience reports Q3 loss per share $0.26

* Q3 earnings per share view $-0.40 -- Thomson Reuters I/B/E/S

03 Nov 2017

BRIEF-Ovascience Q2 loss per share $0.51

* Q2 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S

04 Aug 2017

BRIEF-Ovascience expects $3.5-$4.5 mln in one-time cash items related to June 2017 restructuring

* Anticipates $3.5 million to $4.5 million in one-time cash items related to June 2017 restructuring - sec filing Source text: (http://bit.ly/2tP3fxA) Further company coverage:

22 Jun 2017

BRIEF-Ovascience completes enrollment of 70 patients for clinical study of Ovaprime

* Has completed enrollment of 70 patients in its ongoing clinical study of Ovaprime (sm) treatment

13 Jun 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $138.00 -0.87
Pfizer Inc. (PFE.N) $35.37 -0.19
Merck & Co., Inc. (MRK.N) $55.20 +0.03
Sanofi SA (SASY.PA) €75.43 --
Eli Lilly and Co (LLY.N) $82.89 -0.55
Abbott Laboratories (ABT.N) $55.56 +0.02

Earnings vs. Estimates